These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1534293)

  • 1. Ondansetron to prevent chemotherapy-induced vomiting.
    Drug Ther Bull; 1992 Mar; 30(6):21-3. PubMed ID: 1534293
    [No Abstract]   [Full Text] [Related]  

  • 2. Ondansetron to prevent vomiting after cancer chemotherapy.
    Med Lett Drugs Ther; 1991 Jun; 33(847):63-4. PubMed ID: 1828531
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serotonin as mediator in vomiting reflex: effect of a serotonin3 receptor antagonist in chemotherapy-induced vomiting].
    Layer P
    Z Gastroenterol; 1991 May; 29(5):265-6. PubMed ID: 1835227
    [No Abstract]   [Full Text] [Related]  

  • 4. [New, in Austria registered specialty drugs. Zofran (Ondansetron, Glaxo)].
    Erben M
    Wien Klin Wochenschr; 1991; 103(19):594-601. PubMed ID: 1836917
    [No Abstract]   [Full Text] [Related]  

  • 5. Ondansetron--the first of a new class of antiemetic agents.
    Chaffee BJ; Tankanow RM
    Clin Pharm; 1991 Jun; 10(6):430-46. PubMed ID: 1829668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ondansetron in paediatric patients: a review of three studies.
    Stevens RF
    Eur J Cancer; 1991; 27 Suppl 1():S20-2. PubMed ID: 1831631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for vomiting caused by cancer chemotherapy.
    Med Lett Drugs Ther; 1993 Dec; 35(912):124-6. PubMed ID: 8264505
    [No Abstract]   [Full Text] [Related]  

  • 8. Making chemotherapy easier.
    Grunberg SM
    N Engl J Med; 1990 Mar; 322(12):846-8. PubMed ID: 2137903
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ondansetron--a 5HT 3 receptor antagonist for the treatment of nausea and vomiting induced by cytostatics and radiotherapy].
    Herrstedt J; Ersbøll J; Dombernowsky P
    Ugeskr Laeger; 1991 Apr; 153(18):1292-5. PubMed ID: 1827555
    [No Abstract]   [Full Text] [Related]  

  • 10. [Curative effect of ondansetron on chemically-induced vomiting. Initial results].
    Marty M; Le Bonniec M
    Presse Med; 1991 Jul 6-13; 20(26):1233. PubMed ID: 1831900
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
    Egan AP; Taggart JR; Bender CM
    Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction: the clinical challenge.
    Schmoll HJ
    Eur J Cancer; 1991; 27 Suppl 1():S1-2. PubMed ID: 1831627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ondansetron (GR38032F) for the control of acute and delayed cyclophosphamide-induced emesis.
    Rosso R; Campora E; Cetto G; Fosser V; Marangolo M; Oliva C
    Anticancer Res; 1991; 11(2):937-9. PubMed ID: 1829602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron as an antiemetic.
    Reed MD
    Br J Clin Pharmacol; 1992 Aug; 34(2):144. PubMed ID: 1419476
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs.
    McMillan C; Dundee JW; Abram WP
    Br J Cancer; 1991 Nov; 64(5):971-2. PubMed ID: 1834156
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes.
    Schmoll HJ
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S35-9. PubMed ID: 2533897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron: a new entity in emesis control.
    Graves T
    DICP; 1990 Nov; 24(11 Suppl):S51-4. PubMed ID: 2148659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced nausea and vomiting with special emphasis on metopimazine.
    Herrstedt J
    Dan Med Bull; 1998 Sep; 45(4):412-22. PubMed ID: 9777292
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antiemetic effective for cisplatin-induced emesis.
    Oncology (Williston Park); 1989 Jul; 3(7):79. PubMed ID: 2534945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.